코로나 계열 감염 모두 예방하는 슈퍼 백신 나올까…英서 연말 임상·내년 접종 기대
segye.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from segye.com Daily Mail and Mail on Sunday newspapers.
Cautionary Statement on Forward-looking Information
Certain statements in this press release that are forward-looking and not statements of historical fact are forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and are forward-looking information within the meaning of Canadian securities laws (collectively, “forward-looking statements”). The Company cautions that such statements involve risks and uncertainties that may materially affect the Company’s results of operations. Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including but not limited to, the impact of general economic, industry or political conditions in the United States or internationally; the impact of
A Universal Vaccine May Soon Protect Against All Coronaviruses, Including the Common Cold
On 05/12/21 at 5:00 AM EDT
Jason S. McLellan, associate professor of molecular biosciences, left, and graduate student Daniel Wrapp, right, work in the McLellan Lab at The University of Texas at Austin in 2020.
Vivian Abagiu/College of Natural Sciences at UT Austin
It took Barney Graham, Jason McLellan and their collaborators just a weekend in January 2020 to design a novel vaccine they believed would be capable of protecting people against COVID-19. Their design formed the basis for the vaccines that Moderna, Pfizer and others would eventually use to inoculate millions of Americans a little more than a year later, a pace of development unprecedented in the annals of modern medicine.
These Companies Are Working On Covid Vaccines That Could Stop The Next Pandemic
Share to Facebook
getty
Jeff Baxter, the CEO of Cambridge-based biotech VBI Vaccines, was at an all-hands meeting with his staff at the company’s R&D facility in Canada discussing the worsening Covid-19 pandemic. “I remember it vividly,” he says. A staff member “took me aside and grabbed me by the collar and said, ‘Jeff, we have to do something!’”
The small company, which was incorporated in the U.S. almost 15 years ago, specializes in vaccines for infectious diseases and cancer. But with a market cap of just over $800 million, it couldn’t compete with the other pharmaceutical powerhouses like Pfizer and Moderna, which were able to quickly focus energy on creating a new Covid-19 vaccine. “We weren’t part of the vanguard 5,” Baxter says, referring to the first companies to develop a Covid-19 vaccine, “but we pushed forward.”
vimarsana © 2020. All Rights Reserved.